AIM We performed a meta-analysis with individual participant data of deep brain stimulation (DBS) for dystonia in children and young people.
INTERPRETATION
The data suggest that DBS is effective and should be considered in selected children with inherited or idiopathic dystonia.
Amongst pediatric movement disorders, dystonia is the most common and is often difficult to treat. 1 While pharmacological management has typically been the mainstay of treatment for affected children, poor efficacy and high rates of adverse drug reactions 2 have contributed to increased interest in neurosurgical approaches, and in deep brain stimulation (DBS) especially. In 1999, Coubes et al. 3 were among the first to report on the treatment of a child with dystonia using DBS. Since then, several reports of DBS in children have been published, in part because of dramatic positive outcomes reported for isolated inherited or idiopathic (formerly primary) dystonia 4 and consensus that DBS is generally safe and effective in many adult settings (tardive, DYT1, and myoclonus-dystonia). 5 The data pertaining to DBS in children is, in general, limited to small case series, which hinders the generalizability of results. To our knowledge, no meta-analysis evaluating DBS for childhood dystonia beyond what was formerly known as the primary generalized subgroup exists. 6 The few published literature reviews are not systematic, lack comprehensive details, and do not attempt to quantitatively synthesize the literature to identify meaningful predictors of outcome.
Although highly effective in some patients, it is increasingly recognized that response to stimulation can be variable and difficult to predict. Children with inherited dystonia without nervous system pathology 7 and DYT1 positive status 4 seem to respond better to DBS than those with other forms of dystonia, but little data are available beyond these populations. The need for controlled studies exclusively in pediatric cohorts has been emphasized in the literature. 5 The generalization of data derived from adults to children is limited by several important considerations. These include the potential impact of early intervention on brain and musculoskeletal development as well as differences in the epidemiology of dystonia across the age span, with more acquired rather than inherited dystonia in children. 8 Furthermore, complications such as infection and equipment breakdown may be different in children. 9 A better understanding of outcomes in childhood dystonia is also expected to lead to refinement of indications for DBS, which continue to evolve and expand. Greater awareness of predictors of outcome will inform the conduct of such procedures in children. Here, we performed a systematic review of literature and meta-analysis of DBS for childhood dystonia. Extraction of individual participant data (IPD) was performed from all published studies. The primary objective of our study was to establish the efficacy of DBS across subtypes of dystonia. Our secondary objectives were to identify patient phenotypes associated with treatment response. These data may inform clinical decision-making and surgical candidacy for pediatric DBS.
METHOD Search strategy and eligibility criteria
A systematic review was performed using PRISMA guidelines 10 by searching three electronic databases (PubMed, Embase, and Web of Science) from January 1999 to August 2017 to identify case and cohort studies reporting data on dystonic pediatric (age ≤21y) patients treated with DBS. Inclusion criteria for IPD were: (1) studies reporting outcome using the Burke-Fahn-Marsden (BFM) 11 or Barry-Albright 12 rating scales preoperatively and postoperatively; and (2) pediatric patients in which DBS was used to treat dystonia or status dystonicus. Studies were excluded if: (1) IPD were not available; and (2) children were treated for dystonia parkinsonism.
All articles reporting on DBS for pediatric dystonia, including case reports, were included. We used the following search terms in combination and individually to identify potential studies: 'pediatric deep brain stimulation', 'children deep brain stimulation', 'child deep brain stimulation', and 'dystonia deep brain stimulation'. No language restriction was used.
Two reviewers (LME and AS) with content expertise performed title and abstract screening and full-text review independently. The references of all manuscripts reviewed were used to cross-reference for any missing articles. The names of widely published authors on pediatric dystonia were used as search queries to ensure the quality of the systematic review. Reviewers maintained a list of all citations that were excluded, with justifications. Disagreements were resolved through discussion.
Data extraction
Data were collected independently by two reviewers (LME and HMA), while a third reviewer verified accuracy (GMI). We collected participant data covariates. Covariates collected for IPD included: age at surgery, age at dystonia onset, sex, etiology, dystonia subtype, generalized versus focal distribution, truncal involvement, preoperative and postoperative distribution, status dystonicus at surgery, family history, targeted nuclei, bilateral versus unilateral stimulation, stimulation parameters, reported complications, and follow-up duration. Patients were classified by dystonia etiology (Table I) as per the consensus update proposed by Albanese et al. 13 All data, particularly articles from the same institution, were reviewed for duplicates. All duplicate publications or participants were removed. If there was uncertainty regarding duplicates, the authors of the manuscript were contacted for verification. When publications reporting on duplicate patient cohorts were identified, the larger cohort or the manuscript with the longer follow-up time was included. Almost all included studies were observational, thus carrying inherent limitations regarding methodology and cohort selection. For this reason, bias-risk assessment was not performed.
Endpoints
Outcome measures (BFM Dystonia Rating Scale [BFMDRS] or Barry-Albright Dystonia Scale) were extracted preoperatively, postoperatively, and at last follow-up, when available. The postoperative and last followup outcome scores represent the earliest and latest reported scores after DBS respectively. The primary outcome of interest was the percentage change in scores at last follow-up compared to preoperatively. The scores were adjusted such as that a positive change reflected postoperative improvement. Because of insufficient reporting, other measures of outcome, including pain and functionality, were not included. Significant improvement was defined as To assess potential publication bias, a funnel plot was used to present the observed outcome on the horizontal axis against the standard error of the estimated effect on the vertical axis. A mixed effects meta-regression model was then used to test for funnel plot asymmetry (Fig. S1 , online supporting information).
RESULTS

Search results
The search strategy identified 2509 citations after duplicates were removed from the original 4031 citations (Fig. S2 , online supporting information). A total of 438 manuscripts underwent full-text review. We identified five additional citations after reviewing the references of included studies. Three hundred and sixty-six articles were excluded for the following reasons: outcome not reported in BFMDRS or Barry-Albright scales (n=39), inadequate data separation between adult and pediatric patients (n=28), missing or incomplete data (n=3), duplicate patient population reported in a different study that was included (n=10), and no pediatric patients for IPD (n=286). A complete description of each study is included in Appendices S2 and S3 (online supporting information).
IPD
We extracted IPD from 72 articles (n=321) that met eligibility criteria (Fig. S3 , online supporting information). Of these, 111 children and young people were treated for inherited dystonia without evidence of degeneration or structural lesions, 50 for inherited dystonia with degeneration, 76 for acquired dystonia with static lesions, and 72 for idiopathic dystonia. The remaining 12 patients were included in an alternate group (other or unknown) when the diagnosis stated by the authors was not recognized as having an etiological link to dystonia (i.e. Crigler-Najjar syndrome) or when a diagnosis of secondary dystonia was given without mention of the underlying cause. Eighteen children were treated for status dystonicus. The DBS target was the globus pallidus interna (GPi) in 309 patients, the subthalamic nucleus alone in three patients, a combination of the subthalamic nucleus and GPi in three patients, and the thalamus with or without GPi in three patients. The pedunculopontine nucleus along with the GPi were chosen as targets in a single patient and another received DBS to the internal capsule.
Overall median improvement (interquartile range) in the motor subscore of the BFMDRS was 42.1 percent (12%-80%) with 86.3 percent (n=277) of patients showing any improvement at last follow-up (median 12mo). Significant improvement (>20%) were reported in 66.1 percent (n=203) of patients. Overall median improvement in the disability subscore of the BFMDRS was 27.7 percent (reported in 218 patients). In general, the best responders to DBS were patients with inherited dystonia without degeneration (76.5% median BFMDRS-motor [BFMDRS-M] change) or idiopathic dystonia (50.5% mean BFMDRS-M change). Comparatively, patients with inherited dystonia with nervous system pathology showed less, although still clinically significant (median 26.8%) improvement. Patients with acquired dystonia were the worst responders with a median (interquartile range) change of 10.5 percent (6%-23.1%) in BFMDRS-M score after DBS.
On univariate hierarchical mixed-effects analysis, older age at onset, shorter duration of life with dystonia, inherited dystonia without degeneration (vs all other groups), and truncal involvement were associated with greater improvements in BFMDRS scores after DBS (Table II) . On multivariable analysis, older age at onset, inherited dystonia without nervous system pathology (vs both inherited dystonia with degeneration and acquired dystonia), and presence of truncal involvement were independently associated with greater postoperative improvements (Table III) . No significant difference was observed between inherited dystonia without nervous system pathology and idiopathic dystonia on multivariate analysis.
Inherited dystonia without degeneration or structural lesions
Subgroup analysis was performed on 111 patients with inherited dystonia without nervous system pathology treated with DBS (Table SI, online supporting information). Children and young people included in this group were those with confirmed DYT1 or DYT6 mutations (n=102) or patients with myoclonus-dystonia (n=9), seven of whom had confirmed SGCE (DYT11) mutations. Most (n=107) patients were treated with bilateral GPi stimulation.
The median change in dystonia scores were 76.5 percent (motor) and 70 percent (disability, n=77), with 93.3 percent of children and young people (n=105) demonstrating some improvement and 88.2 percent (n=98) showing clinically significant (>20%) improvement in motor scores at last follow-up (median 13.5mo). A median improvement of 78.1 percent (BFMDRS-M) was reported after DBS at last follow-up (median 15mo) in patients with DYT1/DYT6 dystonia. Patients with myoclonus-dystonia responded similarly well, with a median improvement of 68.3 percent (BFMDRS-M) at last follow-up (mean 10.5mo). All nine patients with myoclonus-dystonia showed clinically significant improvement after DBS. Myoclonic movements improved by 83.3 percent on the Unified Myoclonus Rating Scale rest/action subscore in five patients and by 89.1 percent in Unified Myoclonus Rating Scale total score in one patient.
Inherited dystonia with degeneration or structural lesions
For the 50 children and young people in this group treated with DBS (Table SI) , the median change in motor and disability subscores were 26.8 percent and 0 percent respectively at last follow-up (median 12mo). The most common etiology was pantothenate kinase-associated neurodegeneration (PKAN, n=36) . In general, patients with PKAN dystonia showed clinically significant (median 27.7%, BFMDRS-M) improvement after DBS. Patients with Lesch-Nyhan disease responded similarly well (Table SI) . The worst responders were those with glutaric aciduria type 1 who showed a median change of 6.4 percent on BFMDRS-M after DBS. Except for PKAN dystonia, these findings are limited by small sample size (n=5 for glutaric aciduria type 1, and n=4 for Lesch-Nyhan disease).
Acquired dystonia
The median changes in BFMDRS-M and disability score for 59 children and young people with cerebral palsy were 11.1 percent and 3.5 percent respectively (median followup 12mo). Patients with a history of kernicterus responded negatively (Table SI) , with a median change of 10.5 percent BFMDRS-M postoperatively. Three patients with poststroke dystonia did not show clinically significant improvement after DBS (mean 11.2%) at last follow-up.
Idiopathic dystonia
Patients with idiopathic dystonia improved by 50.5 percent and 39.2 percent on BFMDRS motor and disability scores after DBS respectively. Of 70 patients with BFMDRS data, 80 percent (n=56) showed clinically significant improvement at last follow-up. When compared with the best responders on univariate analysis (inherited dystonia without nervous system pathology), children and young people with idiopathic dystonia responded worse; however, the difference was not significant on subsequent multivariate analysis (Table III) .
Status dystonicus
Eighteen patients were treated for status dystonicus with DBS. Among these patients, six had DYT1 dystonia, five had idiopathic dystonia, three had PKAN, two had Batten disease, 15 and two were of unknown etiology. Median improvement (interquartile range) in motor score was 54 percent (17.7%-88.5%) at last follow-up (median 11mo), with six patients achieving over 85 percent improvement. Resolution of the crisis was observed in 16 out of 18 patients in the postoperative course. One patient did not have information pertaining to resolution of crisis postoperatively but maintained marked improvement at last follow up. Perioperative heart failure and death occurred in one patient treated for status dystonicus.
DISCUSSION
The present study presents the most comprehensive account of the published literature on childhood dystonia treated with DBS using IPD meta-analysis methodology. Several findings are reported. First, the most consistent positive responses to DBS are among patients with inherited dystonia without nervous system pathology (DYT1, DYT6, and myoclonus-dystonia). Generally positive response is also seen in patients with idiopathic dystonia. Poor treatment response is associated with inherited dystonia with nervous system pathology, acquired dystonia, younger ages at dystonia onset, and lack of truncal involvement. Importantly, the current report also highlights shortcomings in the scope and quality of literature evaluating childhood dystonia treated with DBS.
DYT1 dystonia
Our findings support the generally accepted notion that children and young people with DYT1 dystonia respond well to DBS. The significant improvements we report in BFMDRS scores post-DBS is consistent with findings in both adult 16 and pediatric 17 cohorts. When compared with patients with idiopathic dystonia (most of whom had been previously diagnosed with primary dystonia), patients with positive DYT1 genetic status responded significantly better, although patients with idiopathic dystonia still responded well. This finding was also seen in the only other meta-analysis conducted for DBS in primary dystonia, 6 as well as in a meta-analysis which included patients of all ages. 18 
Myoclonus dystonia
We found positive outcomes after DBS in children with myoclonus-dystonia, although the sample size is small (n=9). These results are consistent with results from previous cohorts. 19 DBS seems to improve both dystonia and myoclonus outcome scores significantly. As such, DBS can be considered as a viable treatment option for certain patients with myoclonus-dystonia, particularly those cases confirmed to have mutations in SGCE.
Inherited dystonia with nervous system pathology
The literature pertaining to DBS for this group is comprised of multiple sparsely reported subcohorts, rendering comparison difficult. Combined with highly variable responses, this has led to a debate regarding the selection of DBS as a treatment for these patients. 20 Our findings inform the ongoing discussion. We report highly variable but generally inferior outcomes, a finding consistent in both adult 21 and pediatric 22 cohorts. BFMDRS-M improvements were generally clinically significant in patients with PKAN dystonia and Lesch-Nyhan disease, although results are again variable, 23, 24 and did not reach statistical significance. Perhaps more notably were the effects of DBS on self-mutilating behavior in patients with Lesch-Nyhan disease, with three patients showing complete remission of self-mutilating behavior and one patient showing significant improvement postoperatively. The finding that truncal involvement is associated with better outcomes may be further studied as a means of identifying patients who are most likely to benefit from DBS.
Acquired dystonia
We found poor response (median 11.1% [0%-21.4%], BFMDRS-M) to DBS in patients with one of the most frequent causes of childhood dystonia, cerebral palsy. Although inferior, this result is comparable (mean change 23.6%) to one described in a previous meta-analysis evaluating DBS efficacy in 68 patients of all ages affected by cerebral palsy. 25 Clinically significant improvement after DBS was seen in 27 percent of patients, with only one patient showing more than 50 percent improvement at long-term follow-up. One potential explanation is the increased incidence of structural brain damage, with 70 percent of these children showing structural lesions in the basal ganglia or thalamus on magnetic resonance imaging, 26 although more formal analysis is required before this hypothesis can be recognized.
Some have argued that the BFMDRS is limited in its portrayal of meaningful response to DBS. The BFMDRS was originally designed to assess idiopathic dystonia (formerly primary torsion dystonia) in adults; as such, its validity and sensitivity in pediatric patients with other forms of dystonia has been questioned, especially since there are no adequate reliability studies within this patient population. Authors explain that current available rating systems do not account for important quality of life related elements, including preoperative functional goals 27 and Canadian Occupational Performance Measure functional goal areas, 28 both of which have been shown to improve after DBS in the absence of significant BFMDRS benefit. Furthermore, the BFMDRS does not discriminate between abnormal postures and movements caused by non-dystonic symptoms (i.e. choreoathetosis) and is thus limited to the assessment of a single symptom of a movement disorder. Thus, although inferior outcomes are generally reported in patients with cerebral palsy, DBS should not be ruled out as a treatment option until well-designed studies offer better global understanding of treatment efficacy.
Idiopathic dystonia
Children and young people included in this group generally responded well, with 80 percent of patients showing clinically significant improvement after DBS. The positive results are comparable with those seen in patients with DYT1 or myoclonus-dystonia, as no significant difference between the groups was noted on multivariate analysis. Before the introduction of the Albanese classification, most of the patients with idiopathic dystonia had been previously diagnosed with primary dystonia. As such, it may be unsurprising that they respond so favorably. As more genetic mutations with links to dystonia become recognized, patients in this group may potentially be reclassified as having inherited dystonia without nervous system pathology.
Status dystonicus
Status dystonicus is a potentially life-threatening condition requiring early recognition and intervention. 29 DBS for status dystonicus has been described as an effective method of treating most patients with status dystonicus, 29 although with potentially higher incidence of complications. 30 Our findings support both these claims, with resolution of status dystonicus post-DBS achieved in 16 out of 18 patients and 8 complications among 16 reported. In a recent literature review of DBS for status dystonicus (patients of all ages), cessation of dystonic storm was seen in 26 out of 28 patients, with best outcomes amongst DYT1-positive patients. 31 
Adverse effects
Several studies did not report complications; therefore they were synthesized and presented narratively. Complication rates for DBS in pediatric dystonia remains controversial. Overall, the most commonly reported complications include infections and mechanical failure. Some authors have presented increased rates of infection when compared to adult populations. 7 To address shortcomings in understanding of adverse effects after DBS in children and young people with dystonia, Kaminska et al. analyzed complications in a prospective study including 129 pediatric patients. The overall risk of surgical site infection was 10.3 percent for new implants, with 86 percent of these patients with surgical site infections eventually requiring complete removal of hardware. Despite these numbers, no permanent sequalae pertaining to DBS infection was reported. Another 69 revisions were noted, mostly due to battery changes, highlighting relatively high rates of technical problems. 32 Complication rates of DBS in the pediatric population may be high, but should also be interpreted with knowledge of higher rates of complications in children than adults for other implant procedures, such as ventriculoperitoneal shunting. 7 
Effect of age
The effect of patient age and timing of intervention on DBS outcomes in children remains elusive. Previous authors have suggested that the younger age at which surgery is performed is associated with improved response to DBS. 33 Other authors, including Lumsden et al., have proposed that age at surgery or dystonia onset offers little predictive value with respect to response to DBS; rather, shorter disease duration may be associated with better outcome. 34 In the current analysis, representing the largest synthesis of data on DBS in dystonic children, we found that age at onset of dystonia, and not age at surgery is associated with treatment response. The duration of life with dystonia (i.e. shorter time between diagnosis and DBS) was significant on univariate analysis, but not in the multivariable model. The effects of age and disease duration will continue to be discussed, as pathophysiological mechanisms are elucidated for the role of DBS in dystonia, including neuronal reorganization and plasticity. 35 Other predictors of outcome Importantly, we also find that the severity of preoperative dystonia is not associated with treatment response on either univariate or multivariable analyses. Worse severity of dystonia correlated with inferior treatment efficacy in a previous meta-analyses, 18 findings that were refuted in a thorough review of DBS for dystonia. 5 Further efforts to disentangle the effects of disease severity from collinear covariates, such as age, duration of disease, and dystonia type, are required to reach meaningful conclusions.
There was no correlation between high (>100Hz) versus low stimulation frequency and outcome after DBS. Despite stimulation parameters varying widely among patients, optimal combinations or programming algorithms remain unknown. Potential advantages to low frequency stimulation may include increased battery life and lower complication rates; 36 however, more research is required before these conclusions can be made.
Strength and limitations
The current report represents the most comprehensive analysis of DBS for pediatric dystonia in the literature and the first across all subtypes. While several prior meta-analyses showed stimulation site, etiology, disease duration, 37 and baseline severity 38 were associated with outcomes, these were mostly comprised of adult populations, and lacked comprehensive data extraction and synthesis. A mixed effects meta-regression model provided evidence suggesting funnel plot asymmetry (Fig. S1 ) when evaluating the entire cohort. However, this report evaluates DBS among different dystonic subtypes; therefore, individual funnel plots (stratified by pathology) were also plotted (Fig. S4, online supporting information) . Meta-regression on the individual funnel plots suggested asymmetry only in the inherited without nervous system pathology subgroup. Thus, publication bias may be disproportionately relevant in studies reporting outcomes for inherited dystonia without nervous system pathology.
The current report is the first to synthesize data from inherited, acquired, and idiopathic pediatric dystonia and to summarize the expanding landscape of DBS for these conditions. However, more research is needed. Two multicenter registries for pediatric DBS with uniform data elements and outcomes have already been established. 39, 40 Results from these registries will further contribute to understanding of the role of DBS in children. Further, the first prospective, multicenter trial with planned doubleblind crossover in children and young people with cerebral palsy is underway. In addition to clinical severity, this study will provide important information pertaining to alternative outcome measures, which will help guide selection of surgical candidates. 41 Overall, findings derived from our systematic review are restricted by inherent limitations of meta-analysis. 42, 43 First, although an exhaustive search strategy was used, it is possible that some studies were not identified because of errors in abstract screening or indexing. The current report is the first to include a thorough review of the quality of the data, which in general is of low quality. Finally, and perhaps most importantly, the original articles often did not include important information pertaining to alternate outcomes such as neuropsychological well-being, pain, and quality of life for both children and caregivers, and were therefore not evaluated. Thus, the use of current widely used scales (BFMDRS and Barry-Albright Dystonia) which do not account for these elements likely influences adequate assessment of DBS impact. The International Classification of Functioning, Disability and Health can evaluate alternative areas of DBS influence, including body function and structures, activity, and participation. 44 Despite its introduction in 2001, the International Classification of Functioning, Disability and Health has been scarcely used to assess DBS efficacy. In a recent study, Gimeno and Lin further discuss evaluation of DBS in children with dystonia with respect to the International Classification of Functioning, Disability and Health framework. 44 Moving forward, studies should consider, in addition to clinical severity scales, alternative measures of outcome thus enabling a more holistic assessment of treatment efficacy.
CONCLUSIONS
Patients with DYT1 dystonia tend to have better outcomes. DBS seems to be effective in treating both dystonic and myoclonic symptoms in patients with myoclonus-dystonia. Patients with idiopathic dystonia also respond well. Although less effective in other types of dystonia, DBS may be considered because of the high number of medically refractory patients. DBS should be considered as an emergency treatment for status dystonicus, although it may be associated with greater incidence of complication. Taken together, DBS for childhood dystonia is an effective procedure in carefully selected pediatric cohorts. work. The authors have no conflicts of interest relevant to this article to disclose.
SUPPORTING INFORMATION
The following additional material may be found online: Figure S1 : Funnel plot displaying observed outcome and standard error of the estimated effect for the entire cohort. Figure S2 : PRISMA diagram describing search strategy. Figure S3 : Heterogeneity in response to deep brain stimulation (DBS) in children across all studies. Figure S4 : Funnel plot displaying observed outcome and standard error of the estimated effect stratified by pathology. 
